Holding(s) in Company

RNS Number : 7919T

Synairgen plc

22 July 2020

 

Synairgen plc

("Synairgen" or the "Company")

Holding(s) in Company

Southampton, UK , : Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it was informed on 22 July 2020 that Leonard Licht, a private investor, now holds 7,770,000 ordinary shares of 1 pence  each in the capital of the Company, representing 5.20% of the Company's issued share capital.

Enquiries:

Synairgen plc	[phone]
Richard Marsden (Chief Executive Officer) John Ward (Finance Director)
finnCap - nominated adviser and broker	[phone]
Geoff Nash, Kate Bannatyne, Charlie Beeson (Corporate Finance) Alice Lane, Manasa Patil (ECM)
Consilium Strategic Communications - financial media and investor relations adviser	[phone]
Mary-Jane Elliott, Sue Stuart, Olivia Manser

 

END

 

 

HOLFLFIVDSIFFII